Evidence map›Paper›PMID 39150579›Full record

ArticleJournal of computer-aided molecular design2024

FitScore: a fast machine learning-based score for 3D virtual screening enrichment.

Daniel K Gehlhaar, Daniel J Mermelstein

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of computer-aided molecular design, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Daniel K GehlhaarPfizer, Inc., 10777 Science Center Drive, San Diego, CA, 92121, USA. dan.gehlhaar@pfizer.com.ORCID 0000-0002-7462-5519
Daniel J MermelsteinPfizer, Inc., 10777 Science Center Drive, San Diego, CA, 92121, USA.ORCID 0000-0001-5354-1212

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enhancing virtual screening enrichment has become an urgent problem in computational chemistry, driven by increasingly large databases of commercially available compounds, without a commensurate drop in in vitro screening costs. Docking these large databases is possible with cloud-scale computing. However, rapid docking necessitates compromises in scoring, often leading to poor enrichment and an abundance of false positives in docking results. This work describes a new scoring function composed of two parts - a knowledge-based component that predicts the probability of a particular atom type being in a particular receptor environment, and a tunable weight matrix that converts the probability predictions into a dimensionless score suitable for virtual screening enrichment. This score, the FitScore, represents the compatibility between the ligand and the binding site and is capable of a high degree of enrichment across standardized docking test sets.

Indexed as

Machine LearningMolecular Docking SimulationBinding SitesDrug DiscoveryDrug Evaluation, PreclinicalHumansLigandsProtein BindingProteinsSoftwareLigandsProteinsDockingMachine learningScoringStructure-based designVirtual screening enrichment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.